| Dr Armando Amador Tapia, OD | |
|
710 Lawrence Expy, Santa Clara, CA 95051-5173 | |
| (408) 851-4205 | |
| Not Available |
| Full Name | Dr Armando Amador Tapia |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 710 Lawrence Expy, Santa Clara, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114099363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 8915T (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Armando Amador Tapia, OD 710 Lawrence Expy, Santa Clara, CA 95051-5173 Ph: (408) 851-4205 | Dr Armando Amador Tapia, OD 710 Lawrence Expy, Santa Clara, CA 95051-5173 Ph: (408) 851-4205 |
News Archive
NeoStem, Inc. an international biopharmaceutical company with operations in the U.S. and China and Progenitor Cell Therapy, LLC a privately held cell therapy company that serves the cell therapy industry from licensed, state-of-the art cell therapy manufacturing facilities in New Jersey and California today jointly announced the signing of a definitive merger agreement whereby NeoStem will acquire Progenitor Cell Therapy.
BioDelivery Sciences International, Inc. announced that its commercial partner Meda will launch the FDA-approved ONSOLIS (fentanyl buccal soluble film) next week for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
The combined rate of death from any cause, heart attack or stroke within 18 months was not significantly different in patients with acute coronary syndrome who were randomly assigned to receive dual antiplatelet therapy for either six months or at least 12 months after receiving a drug-eluting stent.
Research led by Dr. Vladimir Hachinski of The University of Western Ontario reveals just how important it is for patients to be referred to a stroke prevention clinic following either a mild stroke or a transient ischemic attack (TIA). The study, published in the journal Stroke in November, showed a 26% reduction in one-year mortality rates among those referred to a stroke prevention clinic.
Montreux Equity Partners, LLC, and GC Aesthetics, Ltd., today announced the completion of a US$30 million private equity investment by Montreux into GCAL. GCAL is a leading designer, manufacturer, and distributor of medical devices for the global aesthetics industry. Montreux entered into the financing agreement with GCAL to accelerate the company's expansion plans.
› Verified 1 days ago
Dr. Jeffery Allen Calmere, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 770 Scott Blvd, Santa Clara, CA 95050 Phone: 408-296-0511 Fax: 408-296-1647 | |
Azinda Morrow, Optometrist Medicare: May Accept Medicare Assignments Practice Location: 770 Scott Blvd, Santa Clara, CA 95050 Phone: 408-296-0511 Fax: 408-296-1647 | |
Nearsite Optometry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5488 Marvell Ln, Santa Clara, CA 95054 Phone: 408-657-6327 | |
Noorie C Dong, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2817 El Camino Real, Santa Clara, CA 95051 Phone: 408-984-2020 Fax: 408-984-2016 | |
Steven Andrew Neunzig, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1190 Scott Blvd, Santa Clara, CA 95050 Phone: 408-241-3510 Fax: 408-247-2605 | |
Eyexam Optometry Optometrist Medicare: Medicare Enrolled Practice Location: 2702 Augustine Dr Ste 120, Santa Clara, CA 95054 Phone: 408-528-7100 |